Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (211-220 of 311) with videos related to

Pageof 32
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 13, 2023
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analysesElaine Limkin, Pierre Blanchard, Benjamin Lacas, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2023
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumoursPaolo Bossi, Ester Orlandi, Carlo Resteghini, et al.
Cancer|March 22, 2012
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 studySusan Urba, Carla M L van Herpen, Tarini Prasad Sahoo, et al.
Oral Oncology|January 18, 2016
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?Cristiana Bergamini, Laura Locati, Paolo Bossi, et al.
Head & Neck|February 6, 2016
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancerSalvatore Alfieri, Carla I Ripamonti, Sara Marceglia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinomaFederica Perrone, Simona Suardi, Elisa Pastore, et al.
Lancet (London, England)|December 5, 2018
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEzra E W Cohen, Denis Soulières, Christophe Le Tourneau, et al.
Oral Oncology|November 8, 2022
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic areaFrancesca Taverna, Salvatore Alfieri, Rebecca Romanò, et al.
Cancer|May 22, 2014
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessmentsLaura D Locati, Lisa Licitra, Laura Agate, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 14, 2020
Management of loco-regionally advanced squamous laryngeal cancer in elderly patientsStefano Cavalieri, Ester Orlandi, Eliana Ivaldi, et al.
Pageof 32

Showing results (211-220 of 311) with videos related to

Sort By:
Pageof 32
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 13, 2023
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analysesElaine Limkin, Pierre Blanchard, Benjamin Lacas, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2023
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumoursPaolo Bossi, Ester Orlandi, Carlo Resteghini, et al.
Cancer|March 22, 2012
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 studySusan Urba, Carla M L van Herpen, Tarini Prasad Sahoo, et al.
Oral Oncology|January 18, 2016
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?Cristiana Bergamini, Laura Locati, Paolo Bossi, et al.
Head & Neck|February 6, 2016
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancerSalvatore Alfieri, Carla I Ripamonti, Sara Marceglia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinomaFederica Perrone, Simona Suardi, Elisa Pastore, et al.
Lancet (London, England)|December 5, 2018
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEzra E W Cohen, Denis Soulières, Christophe Le Tourneau, et al.
Oral Oncology|November 8, 2022
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic areaFrancesca Taverna, Salvatore Alfieri, Rebecca Romanò, et al.
Cancer|May 22, 2014
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessmentsLaura D Locati, Lisa Licitra, Laura Agate, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 14, 2020
Management of loco-regionally advanced squamous laryngeal cancer in elderly patientsStefano Cavalieri, Ester Orlandi, Eliana Ivaldi, et al.
Pageof 32